Parabilis Shares Surge After $745 Million IPO

Drugmaker Parabilis saw its shares soar by 67% following a successful initial public offering and placement that raised $745 million. The company, backed by Regeneron, experienced a significant surge after its record-setting IPO.

Post Share

Sources

Showing 0 of 2 sources

No articles available in your preferred languages.

2 articles available in other languages below.

bloombergFrench59d ago

Drugmaker Parabilis Soars 67% After $745 Million IPO, Placement - Bloomberg

Drugmaker Parabilis Soars 67% After $745 Million IPO, Placement Bloomberg

Read full article →

seeking-alphabcl59d ago

Regeneron-backed Parabilis surges after record-setting IPO

Read full article →

Coverage Timeline

First report: seeking-alpha · 10 Jun, 17:30|Full coverage: 2 · 3h|Window: 3h

Left-leaningCenterRight-leaning

seeking-alpha10 Jun, 17:30First to report

Regeneron-backed Parabilis surges after record-setting IPO

3h later

bloomberg10 Jun, 20:22Latest update

PERSPECTA

PERSPECTA

Parabilis Shares Surge After $745 Million IPO

Sources

Drugmaker Parabilis Soars 67% After $745 Million IPO, Placement - Bloomberg

Regeneron-backed Parabilis surges after record-setting IPO

Coverage Timeline

Regeneron-backed Parabilis surges after record-setting IPO

Drugmaker Parabilis Soars 67% After $745 Million IPO, Placement - Bloomberg

Related Stories

Stock Funds Decline in July Amid AI Volatility

Multiple Companies Release Latest Quarterly Earnings Reports

MTN Nigeria Confirms 25GB Data Reward, Warns Against Fake Links

Renovated Apartment for Sale in Starigrad Paklenica with Sea View

PERSPECTA